These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3266005)

  • 61. In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate.
    Peeters CC; Tenbergen-Meekes AM; Heijnen CJ; Poolman JT; Zegers BJ; Rijkers GT
    J Immunol; 1991 Dec; 147(12):4192-9. PubMed ID: 1753096
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants.
    Insel RA; Anderson PW
    J Exp Med; 1986 Feb; 163(2):262-9. PubMed ID: 3484778
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
    Black SB; Shinefield HR
    Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants.
    Kale KL; King JC; Farley JJ; Vink PE; Cimino CO; Paradiso PR
    Pediatr Infect Dis J; 1995 May; 14(5):350-4. PubMed ID: 7638008
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid.
    Decker MD; Edwards KM; Bradley R; Palmer P
    J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.
    Black SB; Shinefield HR; Fireman B; Hiatt R; Polen M; Vittinghoff E
    Pediatr Infect Dis J; 1991 Feb; 10(2):97-104. PubMed ID: 2062621
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine.
    Weinberg GA; Granoff DM
    Pediatrics; 1990 Apr; 85(4 Pt 2):654-61. PubMed ID: 2179856
    [No Abstract]   [Full Text] [Related]  

  • 70. Reimmunization of children immunized at 18 months of age with Haemophilus influenzae type b vaccine.
    Glode MP; Joffe LS; Brogden R; Kuo J
    J Pediatr; 1988 May; 112(5):703-8. PubMed ID: 3258908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine.
    Gigliotti F; Feldman S; Wang WC; Day SW; Brunson G
    J Pediatr; 1989 Jun; 114(6):1006-10. PubMed ID: 2786061
    [No Abstract]   [Full Text] [Related]  

  • 72. Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.
    Capeding MR; Nohynek H; Käyhty H; Pascual LG; Sunico ES; Tamundong AA; Ruutu P
    Vaccine; 1998; 16(9-10):1004-8. PubMed ID: 9682351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
    Käyhty H; Peltola H; Eskola J
    Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB; Moggio MV; Drucker RP; Wilfert CM
    Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.
    Black SB; Shinefield HR; Lampert D; Fireman B; Hiatt RA; Polen M; Vittinghoff E
    Pediatr Infect Dis J; 1991 Feb; 10(2):92-6. PubMed ID: 2062620
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 37(2):13-6. PubMed ID: 3122004
    [No Abstract]   [Full Text] [Related]  

  • 77. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
    Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
    Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection.
    Gibb D; Giacomelli A; Masters J; Spoulou V; Ruga E; Griffiths H; Kroll S; Giaquinto C; Goldblatt D
    Pediatr Infect Dis J; 1996 Dec; 15(12):1097-101. PubMed ID: 8970219
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
    Granoff DM; Holmes SJ
    Vaccine; 1991 Jun; 9 Suppl():S30-4; discussion S42-3. PubMed ID: 1891954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
    Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.